BNP/CALL/MERCK & CO./145/0.1/20.12.24 Share Price

Warrant

DE000PC5FHE3

Market Closed - Boerse Frankfurt Warrants 20:50:23 31/05/2024 BST
0.19 EUR -.--% Intraday chart for BNP/CALL/MERCK & CO./145/0.1/20.12.24
1 month-42.42%
3 months-42.42%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/05/24 0.19 -.--%
30/05/24 0.19 -.--%
29/05/24 0.19 -5.00%
28/05/24 0.2 -25.93%
27/05/24 0.27 -.--%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5FHE
ISINDE000PC5FHE3
Date issued 21/02/2024
Strike 145 $
Maturity 20/12/2024 (201 Days)
Parity 10 : 1
Emission price 0.29
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.5
Lowest since issue 0.18
Delta0.21x
Omega 12.48
Premium17.19x
Gearing59.34x
Moneyness 0.8658
Difference Strike 19.46 $
Difference Strike %+13.42%
Spread 0.01
Spread %5.00%
Theoretical value 0.1950
Implied Volatility 20.28 %
Total Loss Probability 82.74 %
Intrinsic value 0.000000
Present value 0.1950
Break even 147.12 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW